Results 61 to 70 of about 33,699 (271)
ACTIVATE: the effect of aclidinium/formoterol on hyperinflation, exercise capacity, and physical activity in patients with COPD [PDF]
, 2017 The Phase IV, 8-week, randomized, double-blind, placebo-controlled ACTIVATE study (NCT02424344) evaluated the effect of aclidinium/formoterol (AB/FF) 400/12 mug twice daily on lung hyperinflation ...
Beeh, Kai M. +9 more
core +2 more sources
The once-daily fixed-dose combination of olodaterol and tiotropium in the management of COPD : current evidence and future prospects [PDF]
, 2019 Long-acting bronchodilators are the cornerstone of pharmacologic treatment of chronic obstructive pulmonary disease (COPD). Spiolto (R) or Stiolto (R) is a fixed-dose combination (FDC) containing two long-acting bronchodilators, the long-acting ...
Brusselle, Guy, Derom, Eric, Joos, Guy
core +1 more source
Dual bronchodilation in COPD : lung function and patient-reported outcomes – a review [PDF]
, 2016 Peer reviewedPublisher ...
Ostrem, Anders +3 more
core +2 more sources
Regular treatment with formoterol for chronic asthma: serious adverse events [PDF]
, 2012 Epidemiological evidence has suggested a link between beta(2)-agonists and increases in asthma mortality. There has been much debate about possible causal links for this association, and whether regular (daily) long-acting beta2-agonists are safe ...
Altman +17 more
core +1 more source
Formoterol versus short-acting beta-agonists as relief medication for adults and children with asthma [PDF]
, 2010 Background Formoterol is a long-acting beta(2)-agonist but because it has a fast onset of action it can also be used as a relief medication. Objectives To asses the efficacy and safety of formoterol as reliever therapy in comparison to short-acting ...
Cates, CJ, Welsh, EJ
core +1 more source
Respiratory Research, 2019 Background Long-term use of inhaled corticosteroids (ICSs) has been associated with increased risk of bone and ocular comorbidities. We evaluated the effects of the triple fixed-dose combination budesonide/glycopyrrolate/formoterol fumarate metered dose ...
Edward M. Kerwin +4 more
doaj +1 more source
Effects of Solvents on Skin Permeation of Formoterol Fumarate
Biological and Pharmaceutical Bulletin, 2006 Effects of various chemicals applied as penetration enhancers on the permeation of formoterol fumarate (FF) across excised rat skin were investigated. Remarkable enhancement was noted with terpenes, fatty acid esters, and higher alcohols, whereas no significant influence was observed in the case of lower alcohols, pyrrolidones, and amines.
Ikuhiro, Kakubari +5 more
openaire +3 more sources
Therapeutic Advances in Respiratory Disease, 2018 Introduction: In recognition of the value of long-term real-world data, a postauthorization safety study of the inhaled corticosteroid (ICS) fluticasone propionate and long-acting β 2 -agonist (LABA) formoterol fumarate (fluticasone/formoterol; Flutiform
Vibeke Backer +11 more
doaj +1 more source
Clinical and Translational Science, Volume 19, Issue 2, February 2026.ABSTRACT The Ministerial Ordinance on Good Post‐Marketing Study Practice for Drugs was amended by the Ministry of Health, Labour and Welfare (MHLW) in 2018 to clearly define post‐marketing database studies (DBS) as a measure of pharmacovigilance activities for approved medical products in Japan.
Suguru Okami +2 more
wiley +1 more source
JCSM Communications, Volume 9, Issue 1, January/June 2026.ABSTRACT Introduction Progressive functional decline is a defining feature of cancer cachexia. We evaluated the effects of multicomponent interventions for adults with cancer cachexia on physical function outcomes. We also explored whether changes in physical function outcomes or overall quality of life varied following interventions with or without ...
Megan Bowers +2 more
wiley +1 more source